Willdan Group heads into the final stretch of August with a notable tension at its core: short interest has climbed to a 30-day high while options positioning has simultaneously flipped toward its most bullish reading in months.
The short side of the trade is worth watching closely here. Short interest has risen 20% over the past month to reach 13.5% of the free float — a level that qualifies as meaningfully elevated for a small consulting firm. The week-on-week pace has stayed steady, with shares short ticking up roughly 1.3% over the past five sessions to just under two million shares. That said, the borrow market itself tells a more relaxed story. Availability is running at approximately 345% — well over three shares available for every one already borrowed — meaning there is no meaningful squeeze pressure in the lending pool. Cost to borrow has also fallen sharply, dropping 23% over the week to just 0.41%, near the lowest level of the period surveyed. Shorts are building positions into a cheap, liquid borrow: this looks like a deliberate structural bet, not a technical squeeze setup.
Options, by contrast, have turned notably less defensive. The put/call ratio dropped to 1.05 this week — more than a full standard deviation below its 20-day average of 1.55. That's a sharp reversal from the deeply defensive posture that dominated through late July and into early August, when the PCR held above 1.75 for nearly three weeks straight and briefly touched its 52-week high of 1.96. Whatever drove that elevated hedging demand has dissipated fast, with call volume now pulling the ratio toward the lower end of its historical range. Bears are holding their short positions; options traders appear to have moved the other way.
The Street backdrop supports the more constructive read. Wedbush reiterated its Outperform rating and $130 price target on August 18 — within the past four days — and at the current price of $85.56 that implies roughly 52% upside. That is the only active analyst coverage in the snapshot, so the consensus is thin, but the direction is unambiguous. The bull case centres on Willdan's positioning to benefit from rising US electricity demand: first-half 2025 adjusted EPS grew 125% year-over-year, and the firm generates three to four times the revenue relative to headcount costs, supporting ongoing margin expansion. The bear case points to complexity in the energy infrastructure buildout and competition from private equity-backed rivals willing to overpay for assets. The ORTEX short score has climbed steadily from 60.9 at the start of August to 65.2 now, reflecting the accumulating short-side pressure even as the broader score remains moderate.
Institutional ownership adds another layer of interest. Divisadero Street Capital built a position of 1.32 million shares — 8.7% of shares outstanding — as of June 30, adding over 1.15 million shares in the reported period. Alta Fox Capital and Conversant Capital both appear as new entrants in the same period, each initiating positions. BlackRock added 121,000 shares through July. Insider data is now over 90 days stale, with the most recent disclosed trades being CEO Michael Bieber's May sales of roughly 66,000 shares across multiple tranches near $91–93 — above current levels. Those sales followed an equity award in March, so the pattern looks more like planned liquidation than a directional signal.
Earnings are next due on November 5. The most recent print — delivered August 6 — produced a 16% single-day gain and a 14% five-day follow-through, which goes some way toward explaining the institutional accumulation and the Wedbush reaffirmation. The question heading into Q4 is whether the short interest rebuild, which accelerated sharply after that post-earnings spike, represents a fading of the beat-and-raise momentum or a structural bet against the valuation multiple sustaining at current levels. How the availability and PCR evolve in the weeks before November 5 will be the clearest signal of which camp is gaining ground.
See the live data behind this article on ORTEX.
Open WLDN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
